Agios Pharmaceuticals (AGIO) EPS (Diluted) Growth (3y) (2016 - 2026)
Agios Pharmaceuticals (AGIO) EPS (Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | -16.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.86% |
| Dec 31, 2024 | -201.73% |
| Sep 30, 2024 | 491.87% |
| Jun 30, 2024 | -226.05% |
| Mar 31, 2024 | -27.25% |
| Dec 31, 2023 | -108.54% |
| Sep 30, 2023 | -78.78% |
| Jun 30, 2023 | -131.61% |
| Mar 31, 2023 | -64.67% |
| Dec 31, 2021 | 26.10% |
| Sep 30, 2021 | 68.72% |
| Jun 30, 2021 | 69.07% |
| Mar 31, 2021 | 137.17% |
| Dec 31, 2020 | 73.66% |
| Sep 30, 2020 | 48.28% |
| Jun 30, 2020 | 61.22% |
| Mar 31, 2020 | 30.89% |
| Dec 31, 2019 | -5.68% |
| Sep 30, 2019 | -19.92% |
| Jun 30, 2019 | -26.43% |